Back to search

Article

Treating a Pandemic Respiratory Disease with a Mutagen is a Doomsday Scenario 

2022-01-21

Abstract excerpt

Merck's Molnupiravir is a global catastrophic risk. Its broad use as a treatment for COVID-19 will create dangerous variants of SARS-COV-2. It is already in use in some countries. Molnupiravir ("MOLN"), a presumed anti-COVID19 drug, acts by significantly increasing the RNA error rate in the coronavirus replication. That exponentially increases the probability of many mutations in a single copy. Copies containing a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db51c6ec-071a-55ad-bd46-e3ea0c6a1ecb
DOI
10.22541/au.163854323.34557301/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Treating a Pandemic Respiratory Disease with a Mutagen is a Doomsday ScenarioDOI 10.22541/au.163854323.34557301/v2
Select a neighboring publication to make it the new centre.